Riskpilot← Back to searchSign inGet full accessTriplex LAB AB
ABActiveOrg 5592895790Bjurgränd 5 Lgh 1401Other specialised construction activities n.e.c. · NACE 4399Est. 20201-4 employees
Revenue 2024
SEK 5,4M
+18% vs 2023
EBITDA margin
9.6%
+556% vs 2023
Equity ratio
29.5%
Financial strength
Net profit 2024
SEK 280K
+499% vs 2023
| Revenue | SEK 5,4M | +18% |
| EBITDA | SEK 516K | +556% |
| Net profit | SEK 280K | +499% |
| Total assets | SEK 1M | +38% |
| Equity | SEK 305K | +304% |
| Employees | — | — |
Legal name
Triplex LAB AB
Org number
5592895790
Legal form
Aktiebolag
NACE code
4399 · Other specialised construction activities n.e.c.
Founded
11 december 2020
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Kundanpassad konsultverksamhet inom data, web och IT så som design, produktion, programmering och utveckling. Konsultverksamhet inom företagsutveckling, mediaproduktion och marknadsföring.
Address
Bjurgränd 5 Lgh 1401
Email
info@triplexlab.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 17 | 22 | 4 573 | 5 398 |
| Staff expenses | — | — | −1 514 | −2 011 |
| EBITDA | 2 | 7 | 79 | 516 |
| Depreciation & amort. | −0 | −5 | −18 | −45 |
| EBIT | 2 | 2 | 61 | 472 |
| Net financials | — | — | −0 | −1 |
| Profit before tax | 2 | 2 | 61 | 361 |
| Tax | −0 | −0 | −14 | −81 |
| Net profit | 2 | 2 | 47 | 280 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 36 | 29 | 753 | 1 035 |
| Equity | 27 | 29 | 76 | 305 |
| Long-term debt | 0 | 0 | — | — |
| Short-term debt | 9 | 0 | 677 | 620 |
| Total debt | 9 | — | 677 | 620 |
EBITDA margin
9.6%
This company
15.8%
Market median
-39% vs market
20212024
Equity ratio
29.5%
This company
38.2%
Market median
-23% vs market
20212024
Return on equity
91.6%
This company
18.4%
Market median
+398% vs market
20212024
Net profit margin
5.2%
This company
8.1%
Market median
-36% vs market
20212024
Asset turnover
5.21×
This company
1.12×
Market median
+365% vs market
20212024
Debt / equity
2.39×
This company
0.62×
Market median
-285% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
VC Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2023 |
DC Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
VS Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Triplex LAB AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Valeria Sipos | Deputy Chief Executive Officer | 0 companies |
| Valeria Cherman | Deputy Chief Executive Officer | 0 companies |
| Daniel Cherman | Chief Executive Officer | 0 companies |
| Aleksandr Sipos | Chairman | 0 companies |